Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
Financials
Financial year 2025
BOIRON from Evere, company number BE0541731340, closed financial year 2025 with a result of € 438,419 after tax. For that financial year BOIRON recorded revenue of € 12.2 million and equity of € 6.6 million. Compared with financial year 2024, the result moved from € 146,111 to € 438,419. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
€ 6.6 million
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 438,419
▲ 200% vs 2024
Profit after tax over the fiscal year.
€ 6
▼ € 4,293 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -4.4 million.
People and assets in 2025
59.7
▼ 2.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 5.1 million
▼ 1% vs 2024
€ 85,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 9,054
▲ 127% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.4 million
▲ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 81 days on average.
€ 1 million
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 16,666,359 | € 12,015,860 | € 12,227,590 | € 12,189,750 | |
| Profit after taxes | € 281,422 | € -1,627,678 | € 146,111 | € 438,419 | ▲ 200% |
| Equity | € 7,632,872 | € 6,005,194 | € 6,151,305 | € 6,589,724 | ▲ 7% |
| Total debts | € 2,431,832 | € 2,865,212 | € 2,067,004 | € 2,653,002 | ▲ 28% |
| Cash | € 3,547 | € 3,271 | € 4,299 | € 6 | ▼ € 4,293 |
| Land & buildings | € 3,758,581 | € 2,101,296 | € 2,078,683 | € 2,137,125 | ▲ 3% |
| Retained profit | € -3,385,678 | € -5,013,356 | € -4,867,245 | € -4,428,826 | ▲ € 438,419 |
| Balance sheet total | € 10,117,329 | € 8,881,545 | € 8,226,207 | € 9,247,088 | ▲ 12% |
| Employees (FTE) | 67.1 | 64.7 | 62.2 | 59.7 | ▼ 2.5 |
Key figures of BOIRON, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BOIRON?
What happened at BOIRON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 438,419 (▲ 200% vs 2024). Source: NBB ↗
- Roland Vermoote became a director. NBB
- Eduardo Barriga Garcia stepped down as director. NBB
- Eduardo Barriga Garcia became a director. NBB
- Christelle Caillet stepped down as director. NBB
- Christelle Caillet became a director. NBB
- New establishment in Evere. KBO
- New establishment in Evere. KBO
In short
From € 281,422 profit in 2022 to € 438,419 profit in 2025.
Paid € 137,905 in corporate taxes since 2022.
Best year ever: 2025, with € 438,419 profit.
Pays suppliers within 81 days on average.
A new publication or filing at BOIRON? We notify you, reason included.
Follow BOIRONDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BOIRON is Roland Vermoote. The shares are held by BOIRON SA (100%).
Directors
According to the 2025 annual accounts
Roland Vermoote
Director
since 2025
Eduardo Barriga Garcia
Director
since 2025 · until 2025
Christelle Caillet
Administratrice
since 2022 · until 2025
Shareholders
BOIRON SA
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Carlistraat 5
1140 Evere
Carlistraat 3
1140 Evere
Active since 7 February 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0541.731.340
- VAT number
- BE 0541.731.340
- Registered office
- Carlistraat 5, 1140 Evere
- Names & denominations
- BOIRON
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 November 2013
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van overige farmaceutische producten
Detailhandel in farmaceutische producten
Vervaardiging van gehomogeniseerde voedingspreparaten en dieetvoeding
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Groothandel in farmaceutische en medische artikelen